Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

Top Ten Advances in IBD 2023

Northwestern Medicine Gastroenterology

S. Hanauer

ACAAI 2024 Insights: The Bench to Bedside Pathway to Bring a Biologi…

ACAAI 2024 Insights

T. B. Casale

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

DDW 2023 Conference Coverage

S. Hanauer

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman

Leukocyte Trafficking Agents in the Management of IBD

Washington University in St. Louis

K. Huff-Hardy

Rethinking Current and Future Treatment Sequence of Moderate to Seve…

Columbia University

E. Scherl

Starting IBD Patients on Biologic Therapy: How Long to Wait Before D…

Neeraj Narula

Update of Anti-Integrin Therapy in IBD

Columbia University

B. Sands

Medical Therapy in IBD: Past, Present, and Future

David Choi

Hot Off the Press: What Are We Currently Using? Novel Approved IBD T…

Cedars Sinai

R. Ungaro

Biosimilar Medications in Rheumatology: Update

Keck School of Medicine of USC

J. Cho

Update of Oral Small Molecules in IBD

Columbia University

U. Navaneethan

Anti-Interleukin Therapy in IBD

Washington University in St. Louis

A. Gremida

Managing Fertility, Pregnancy and Nursing in IBD

Scripps Health: 2019 Inflammatory Bowel Disease

U. Mahadevan

Medical Therapy of IBD with Anti-TNF in Pediatric Patients

Columbia University

J. Picoraro

DDW 2023 Updates and Perspectives in IBD

Northwestern Medicine Gastroenterology

S. Hanauer